A share price of Pediatrix Medical Group Inc [MD] is currently trading at $9.58, up 0.31%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MD shares have gain 2.90% over the last week, with a monthly amount glided 5.62%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, February 2024, Pediatrix Medical Group Reports Fourth Quarter Results. In a post published today on Yahoo Finance, Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported a loss from continuing operations of $1.50 per share for the three months ended December 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32.
From an analyst’s perspective:
Pediatrix Medical Group Inc [NYSE: MD] stock has seen the most recent analyst activity on September 27, 2021, when SVB Leerink initiated its Mkt Perform rating and assigned the stock a price target of $29. On October 19, 2020, downgrade downgraded it’s rating to Sell and revised its price target to $12 on the stock. Citigroup downgraded its rating to a Neutral but stick to its price target of $29 on January 03, 2020. Stifel upgraded its rating to a Buy and raised its price target to $33 on December 12, 2019. BofA/Merrill downgraded its rating to Underperform for this stock on September 06, 2019. In a note dated January 15, 2019, Citigroup upgraded an Buy rating on this stock.
Pediatrix Medical Group Inc experienced fluctuations in its stock price throughout the past year between $7.70 and $15.20. Currently, Wall Street analysts expect the stock to reach $24.67 within the next 12 months. Pediatrix Medical Group Inc [NYSE: MD] shares were valued at $9.58 at the most recent close of the market. An investor can expect a potential return of 157.52% based on the average MD price forecast.
Analyzing the MD fundamentals
Trailing Twelve Months sales for Pediatrix Medical Group Inc [NYSE:MD] were 1.99B which represents -3.39% decline. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.05 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.32 points at the first support level, and at 9.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.72, and for the 2nd resistance point, it is at 9.87.
Pediatrix Medical Group Inc [MD] reported earnings per share of $0.32 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.32/share, meaning a difference of $0 and a surprise factor of 0.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.32 per share as compared to estimates of $0.43 per share, a difference of -$0.11 representing a surprise of -25.60%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pediatrix Medical Group Inc [NYSE:MD] is 1.38. Further, the Quick Ratio stands at 1.20, while the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 0.40, the price to book ratio is 0.83.
Transactions by insiders
Recent insider trading involved Swift James D, Chief Executive Officer, that happened on Dec 14 ’23 when 5764.0 shares were sold. EVP, General Counsel & Sec, Moore Mary Ann E completed a deal on Dec 14 ’23 to sell 1150.0 shares. Meanwhile, EVP, General Counsel & Sec Moore Mary Ann E sold 970.0 shares on Dec 14 ’23.
